Phase II trial of clinical activity and safety of ceritinib combined with stereotactic ablative radiotherapy (SABR) in lung adenocarcinoma patients.

被引：0
|
作者：
Khan, Saad A.
Gerber, David E.
Zhu, Hong
Hughes, Randall S.
Mannala, Samantha
Rashdan, Sawsan
Dowell, Jonathan
Westover, Kenneth D.
Saltarski, Jessica
Harrah, Kasia
Priddy, Laurin
Choy, Hak
Timmerman, Robert D.
Brekken, Rolf A.
Sorrelle, Noah
Iyengar, Puneeth
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] Univ Texas Southwestern, Irving, TX USA
[3] Univ Texas Southwestern Med Ctr, Ft Worth, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21571
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort
    Murray, L.
    Ramasamy, S.
    Lilley, J.
    Snee, M.
    Clarke, K.
    Musunuru, H. B.
    Needham, A.
    Turner, R.
    Sangha, V.
    Flatley, M.
    Franks, K.
    CLINICAL ONCOLOGY, 2016, 28 (01) : 4 - 12
  • [42] Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
    Palma, David A.
    Olson, Robert
    Harrow, Stephen
    Gaede, Stewart
    Louie, Alexander V.
    Haasbeek, Cornelis
    Mulroy, Liam
    Lock, Michael
    Rodrigues, George B.
    Yaremko, Brian P.
    Schellenberg, Devin
    Ahmad, Belal
    Senthi, Sashendra
    Swaminath, Anand
    Kopek, Neil
    Liu, Mitchell
    Moore, Karen
    Currie, Suzanne
    Schlijper, Roel
    Bauman, Glenn S.
    Laba, Joanna
    Qu, X. Melody
    Warner, Andrew
    Senan, Suresh
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (25) : 2830 - +
  • [43] Stereotactic Body Radiotherapy Combined with Sintilimab in Patients with Recurrent or Oligometastatic Hepatocellular Carcinoma: A Phase II Clinical Trial
    Chen, Y.
    Yang, P.
    Du, S.
    Zhuang, Y.
    Hu, Y.
    Zeng, Z. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S106 - S107
  • [44] Quality of Life and Symptoms in Patients Undergoing Stereotactic Ablative Body Radiotherapy (SABR) for Early Stage Lung Cancer
    Gray, C.
    Wingate, E.
    Ghafoor, Q.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E56 - E56
  • [45] IAEA RCA 6065: IMPROVING ACCESS TO STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) FOR LUNG CANCER PATIENTS IN ASIA
    Hegi-Johnson, Fiona
    Siva, Shankar
    Foote, Matthew
    Tan, Daniel
    Kim, Mi-Sook
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1130 - S1130
  • [46] Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial
    Chen, Yi-Xing
    Yang, Ping
    Du, Shi-Suo
    Zhuang, Yuan
    Huang, Cheng
    Hu, Yong
    Zhu, Wen-Chao
    Yu, Yi-Yi
    Liu, Tian-Shu
    Zeng, Zhao-Chong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (24) : 3871 - 3882
  • [47] Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients
    Saha, Animesh
    Beasley, Matthew
    Hatton, Nathaniel
    Dickinson, Peter
    Franks, Kevin
    Clarke, Katy
    Jain, Pooja
    Teo, Mark
    Murray, Patrick
    Lilley, John
    RADIOTHERAPY AND ONCOLOGY, 2021, 156 : 153 - 159
  • [48] Phase II randomized clinical trial comparing immunotherapy plus stereotactic ablative radiotherapy (I-SABR) versus SABR alone for stage I, selected stage IIa or isolated lung parenchymal recurrent non-small cell lung cancer: I-SABR.
    Chang, Joe Y.
    Feng, Lei
    Lin, Steven H.
    Welsh, James William
    Antonoff, Mara
    Gomez, Daniel Richard
    Heymach, John
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] A randomised phase II trial of single fraction or multi-fraction SABR (stereotactic ablative body radiotherapy) with atezolizumab in patients with advanced triple negative breast cancer (AZTEC trial)
    David, Steven
    Savas, Peter
    Siva, Shankar
    White, Michelle
    Neeson, Michael W.
    White, Shane
    Marx, Gavin
    Cheuk, Robyn
    Grogan, Michelle
    Farrell, Maria
    Foudoulis, Jessica
    Dempsey, Annette
    Neeson, Paul J.
    Bressel, Mathias
    Loi, Sherene
    CANCER RESEARCH, 2022, 82 (04)
  • [50] Can Clinical Variables be used to Provide Better Follow up in Stereotactic Ablative Radiotherapy (SABR) Treated Lung Cancers?
    Hatton, N.
    Saha, A.
    Beasley, M.
    Franks, K.
    Clarke, K.
    Jain, P.
    Teo, M.
    Murray, P.
    Lilley, J.
    Dickinson, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S142 - S142
12345